FDA Advises Against Using Dietary Supplement Glutathione for Injectable Preparations

The U.S. Food and Drug Administration (FDA) has issued a reminder to compounders regarding patient safety. The agency advises against using dietary supplement grade glutathione for injectable preparations, emphasizing regulatory adherence to ensure the safety and efficacy of compounded medications. This guidance aims to prevent potential health risks associated with inappropriate ingredient sourcing.